Leukaemia Trial, Recruiting NCT07405424 Sponsor: University of Chicago Condition: Leukaemia
Back to Leukaemia

Leukaemia Trial, Recruiting

NCT07405424
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with Acute Leukemia (either AML or ALL) and are currently receiving your first treatment in hospital
  • You are able to read, understand, and speak English
  • You are willing and able to understand and sign a consent form agreeing to take part

Who may not be able to join:

  • You are not able or willing to take part in the spiritual care activities involved in the trial
  • Your leukemia has come back after treatment or has stopped responding to treatment
  • You have cognitive difficulties (such as memory or thinking problems) that would make it hard to take part or complete survey questions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wendy Stock, University of Chicago

Phone: 1-855-702-8222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 June 2026
Est. completion
16 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Is it feasible to enroll patients to a spiritual intervention study?; Will patients accept using the study specific spiritual intervention?

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov